Current Opinion in Infectious Diseases

Article	Citations
La Crosse virus encephalitis in children	73
Skin and soft tissue infections: swab or biopsy? A diagnostic dilemma	66
Strongyloidiasis-related lung involvement: too much of a bad thing	64
Hematopoietic stem cell transplantation and cellular therapy in persons living with HIV	56
Postexposure prophylaxis for occupational exposure to selected pathogens for healthcare personnel	54
Surgical management of cystic echinococcosis of the liver	51
Prevention is all you need: generative artificial intelligence for infection prevention and healthcare epidemiology	48
From diagnosis to management: current perspectives on congenital cytomegalovirus infection	44
Complexities of cardiomyopathy in septic shock	35
Corticosteroids for viral central nervous system infections	34
Bacterial cholesterol-dependent cytolysins and their interaction with the human immune response	33
Skin and soft tissue infections in the elderly	33
Editorial introductions	32
Tissue resident memory T cells in respiratory infections	31
Babesiosis in immunosuppressed hosts: pathogenesis, diagnosis and management	30
Typhoid fever control in the 21st century: where are we now?	29
Fusarium species central nervous system infection	29
Viral meningitis and encephalitis: an update	28
Managing cognitive impairment in people with HIV: Erratum	27
Resistant herpes simplex virus infections – who, when, and what's new?	26
Follow-up blood culture in Gram-negative bacilli bacteraemia: for whom is follow-up blood culture useful?	24
Tropical infectious diseases and skin manifestations: a diagnostic framework	23
Malaria in pregnancy: baby steps	23
Mpox in people living with HIV	21
Tuberculosis molecular bacterial load assay in the management of tuberculosis	21

The reemergence of Streptococcus pyogenes in skin and soft tissue infections: a review of epidemiology, pathogenesis, and management strategies	21
Tick-borne encephalitis	20
Appropriate surgical management in skin and soft tissue infections	20
Editorial introductions	20
CMV antiviral stewardship in transplantation – the next frontier	19
Using antibiotics wisely	19
Interventions for polyoma virus-associated hemorrhagic cystitis	19
Management of neonates born to mothers with active genital herpes simplex virus infection: an alternative approach	18
New diagnostic strategies to distinguish Crohn's disease and gastrointestinal tuberculosis	18
Does climate change threaten delivery of HIV care in resource-limited settings?	18
Haemophilus ducreyi in genital ulcer disease: new developments in an old disease	18
Gut microbiome and its clinical implications: exploring the key players in human health	18
Large lessons learned from small vessels: coronary microvascular dysfunction in HIV	17
Diagnostic stewardship: what impacts antibiotics use?	17
The plumbing problem: rising antimicrobial resistance in building water systems	17
Recent advances in flavivirus encephalitis	17
Risk stratification for selecting empiric antibiotherapy during and after COVID-19	16
Prenatal and postnatal antiviral therapies for the prevention and treatment of congenital cytomegalovirus infections	16
How to differentiate skin rash in covid, mononucleosis, chickenpox, sixth disease and measles	16
Update on the treatment of chronic pulmonary aspergillosis	16
Human adenovirus lung disease: outbreaks, models of immune-response-driven acute lung injury and pandemic potential	15
Childhood tuberculosis	15
Editorial introductions	15
The secret weapon to reduce multidrug-resistant Gram-negative infections: can vaccines help decrease MDR risk?	15
Respiratory syncytial virus in children: epidemiology and clinical impact post-COVID-19	15
Interpreting and managing preservation fluids positive for Gram-negative bacteria	14
Travellers’ diarrhoea – solidifying our knowledgebase	14
New trends in congenital syphilis: epidemiology, testing in pregnancy, and management	14
The role of macrolides in severe community-acquired pneumonia and the potential impact of macrolide-resistant Mycoplamsa pneumoniae	14
Respiratory metagenomics: route to routine service	14
Data science for pediatric infectious disease: utilizing COVID-19 as a model	14
Respiratory syncytial virus prevention in immunocompromised hosts: gaps and opportunities	14
Combatting antimicrobial-resistant Neisseria gonorrhoeae: new antibiotics and the pipeline of antigonococcal therapeutics	14
Chronic persistent Norovirus in the immune-compromised host	14
The microbiome as a biomarker of anal precancerous lesions in people with HIV	14
Advanced neuroimaging for central nervous system infections: when, where, how, and why?	13
Emerging treatment options for skin and soft tissue infections tailoring drug selection to individual patients	13
Emerging infections in vulnerable hosts: Stenotrophomonas maltophilia and Elizabethkingia anophelis	13
Update on drug treatments for multidrug resistant tuberculosis	13
Short treatment duration for community-acquired pneumonia	13
Use of gloves: current evidence vs. current use	12
Antibiotic therapy for nonfermenting Gram-negative bacilli infections: future perspectives	12
Antiviral therapies for respiratory syncytial virus infection: current expectations	11
H5 and H9 avian influenza – potential re-emergent zoonotic threats to humans	11
The disease burden of respiratory syncytial virus in Infants	11
Urinary tract infections in immunocompromised patients	11
An overview of risk factors, management and prevention of cochlear implant infections	11
Identifying patients with difficult-to-treat acute bacterial skin infections	11
Burden of influenza in the elderly: a narrative review	10
Skin and soft tissue infections in solid organ transplants	10

Short-course antibiotic strategies for ventilator-associated pneumonia	10
Anti-inflammatory therapies for bronchiectasis	10
Genetic mechanisms underlying host susceptibility to central nervous system viral infections	10
Neurobrucellosis	10
Resurgence of Mycoplasma pneumoniae infections in children: emerging challenges and opportunities	10
A new era of HIV care for age-associated multimorbidity	10
Duration of antibiotic therapy in Gram-negative infections with a particular focus on multidrug-resistant pathogens	9
Updates on the neurological manifestations of SARS-CoV-2 infection	9
Chagas disease in the immunocompromised host	9
Latent tuberculosis screening and treatment in solid organ and hematopoietic stem cell transplant candidates and recipients	9
Therapeutic agents for the treatment of human mpox	9
How I manage patients with New Delhi metallo-beta-lactamase and OXA-48-producing Enterobacterales infections: a practical approach	9
The evolution of knowledge for treating Gram-negative bacterial infections	9
Pneumocystis jirovecii in solid organ transplant recipients: updates in epidemiology, diagnosis, treatment, and prevention	9
Immune responses and severe dengue: what have we learned?	9
Eravacycline: from clinical trials to its potential place in everyday therapy	9
Endemic, epidemic and pandemic infections: the roles of natural and acquired herd immunity	9
Genome-wide approaches to bacterial strain typing: a history and review of recent methodological advances	9
Pneumocystis jiroveci: still troublesome to diagnose and treat	8
Effective strategies for managing trimethoprim-sulfamethoxazole and levofloxacin-resistant Stenotrophomonas maltophilia infections: bridging the gap between scientific evidence and clinical practice	8
Live vaccines in solid organ transplant recipients	8
Dengue and chikungunya vaccines past, present and future: implications for travelers	8
Management of nonfermenting gram-negative infections: a critique of the guidelines	8
The implications of the COVID-19 pandemic for long term care facilities	8
Surgical site infection prophylaxis: what have we learned and are we making progress?	8
Endemic viral infections in immunocompromised hosts: Dengue, Chikungunya, Zika	8
Editorial introductions	8
Universal versus targeted treatment of neonatal herpes simplex virus among neonates presenting for sepsis evaluations	8
Mycetoma, chromoblastomycosis and other deep fungal infections: diagnostic and treatment approach	8
The role of older antibiotics in the treatment of skin and soft tissue infections: current perspectives	8
Tropical gastrointestinal infections of contemporary public health importance	8
Editorial introductions	8
Chimeric antigen receptor-T-cell therapies going viral: latent and incidental viral infections	7
Long COVID in children and young people: then and now	7
Antiviral therapies for influenza	7
Preventing respiratory viral transmission in healthcare settings	7
When is it a sexually transmitted infection? Intimate contact transmission of pathogens not traditionally defined as STIs	7
Editorial introductions	7
Editorial introductions	7
An update on infectious encephalitis: from epidemiology to management	7
Medical management of cystic echinococcosis	7
Recent advances in the management of skin and soft tissue infections	7
Giardia and growth impairment in children in high-prevalence settings: consequence or co-incidence?	6
Redefining tissue immunity: lessons from the CNS and beyond	6
Horizontal versus vertical strategies for infection prevention: current practices and controversies	6
The return of measles: a dangerous comeback	6
Donor-derived latent viral and parasitic infections in solid organ transplant recipients: old foes and emerging challenges	6
The power of story: what Victorian novels can teach us about public health	6
Empirical antibiotic therapy for difficult-to-treat Gram-negative infections: when, how, and how long?	6
Risk factors for severity in seasonal respiratory viral infections and how they guide management in hematopoietic cell transplant recipients	6
From clinical trials to daily practice: how to adequately administer sulbactam-durlobactam? alone or combined with imipenem?	6
Understanding challenges to prevention of healthcare related infections	6
Community-acquired skin and soft-tissue infections in people who inject drugs	6
Is it possible to identify genotypes underlying resistant phenotypes in Gram-negative pathogens?	6
Current status of primary, secondary and tertiary prevention of congenital cytomegalovirus disease: a call to action	6
Risk factors for cognitive decline in persons with HIV	6
Editorial introductions	6
Climate change and resilience for antimicrobial stewardship and infection prevention	6
Current challenges in neurocysticercosis: recent data and where we are heading	5
Editorial introductions	5
Viral infections and inborn errors of immunity	5
Managing multidrug resistant Gram-negative bacteraemia in immunocompromised hosts	5
The role of sulbactam-durlobactam in treating carbapenem-resistant Acinetobacter infections	5
Lenacapavir: a first-in-class capsid inhibitor for HIV treatment and prevention	5
Editorial introductions	5
‘No cyst, no echinococcosis’: a scoping review update on the diagnosis of cystic echinococcosis after the issue of the WHO-IWGE Expert Consensus and current perspectives	5
Vaccine hesitancy and other challenges to sexually transmitted infection vaccine acceptance	5
Antiviral combination treatment strategies for SARS-CoV-2 infection in immunocompromised patients	5
Editorial introductions	5
Viral diarrheas – newer advances in diagnosis and management	5
Central nervous system infections in the tropics	5
Neutropenia and antibiotics: when, what, how and why?	5
To proceed or delay? The dilemma of community-acquired respiratory viruses in adults and pediatrics before allogeneic stem cell transplantation and chimeric-antigen-receptor T-cell therapy	5
Dengue encephalitis: what's new?	5
Strongyloides stercoralis infection in solid organ transplant recipients	5
Cutaneous manifestations associated with HIV preexposure prophylaxis: what to expect and when to worry	5
Shifting the power: scale-up of access to point-of-care and self-testing for sexually transmitted infections in low-income and middle-income settings	5
Human toxoplasmosis: current advances in the field	5
The microbiology and pathogenesis of nonfermenting Gram-negative infections	5
Skin and soft tissue infections due to rapidly growing mycobacteria	5

Nontyphoidal Salmonella infections acquired from poultry	5
Advances and challenges in sexually transmitted infections prevention among men who have sex with men in Asia	5
Mpox: emergence following smallpox eradication, ongoing outbreaks and strategies for prevention	4
HIV and menopause: current evidence, gaps, and future directions for integrated care	4
Mpox exposure and transmission in healthcare settings during the 2022 global outbreak	4
Impact of respiratory viral infections on nasopharyngeal pneumococcal colonization dynamics in children	4
The role of the genital microbiota in the acquisition and pathogenesis of sexually transmitted infections	4
Respiratory viral infections in children with cancer and febrile neutropenia and children undergoing hematopoietic stem cell transplantation	4
Updates on diagnosis and management of parasitic infections of the central nervous system	4
Lenacapavir and the novel HIV-1 capsid inhibitors: an emerging therapy in the management of multidrug-resistant HIV-1 virus	4
Infant feeding: emerging concepts to prevent HIV transmission	4
When antimicrobial stewardship begins with microbiological test requests: the case of asymptomatic bacteriuria	4
The present and future of blood virome in allogeneic hematopoietic cell transplant recipients	4
Infectious mononucleosis: new concepts in clinical presentation, epidemiology, and host response	4
A work in progress: antimicrobial stewardship in solid organ transplant patient populations	4
Clinical trials that could change the management of severe multidrug-resistant Gram-negative infections	4
Epidemiology of Gram-negative bacteria during coronavirus disease 2019. What is the real pandemic?	4
Editorial introductions	4
How to treat severe Acinetobacter baumannii infections	4
Host-directed immunotherapy for viral infections	4
Harnessing next-generation microbial diagnostics to optimize infection management in immunocompromised hosts	4
Vitamin D for tuberculosis or acute respiratory infections: lost in translation?	4
Antiviral prophylaxis against herpesviruses (herpes simplex virus, varicella-zoster virus and cytomegalovirus) among patients with cancer	4
NSAIDs for early management of acute respiratory infections	4
Gastrointestinal involvement in post-acute Coronavirus disease (COVID)-19 syndrome	4
New antibiotics in clinical pipeline for treating infections caused by metallo-β-lactamases producing Gram-negative bacteria	4
Endemic mycoses – are we making progress in management?	4
Left ventricular assist device-associated driveline infections as a specific form of complicated skin and soft tissue infection/acute bacterial skin and skin structure infection – issues and therapeut	4